Shanghai Pharmaceuticals Holding Co (HKSE:02607) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 01, 2026)


HKSE:02607 Shanghai Pharmaceuticals Holding Co Ltd HKSE:02607
87 GF Score
Price HK$11.40
GF Value HK$14.54
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Shanghai Pharmaceuticals Holding Co Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Shanghai Pharmaceuticals Holding Co's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

HKSE:02607 vs MCK, CAH, COR: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Pharmaceuticals Holding Co Margin of Safety % (DCF FCF Based) vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's Margin of Safety % (DCF FCF Based) falls into.


HKSE:02607
87GF Score
Shanghai Pharmaceuticals Holding Co Ltd HKSE:02607
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shanghai Pharmaceuticals Holding Co (HKSE:02607) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued. The current stock price of HK$11.40 is trading 21.6% below its estimated GF Value™ of HK$14.54. GuruFocus considers Shanghai Pharmaceuticals Holding Co to be Modestly Undervalued.

Key valuation signals for HKSE:02607:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: HK$14.54 vs. price of HK$11.40 (21.6% below fair value)
  • GF Score™: 87/100 with 4 warning signs

No single metric tells the full story. See the HKSE:02607 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Pharmaceuticals Holding Co Business Description

Other Exchanges S1R:Germany601607:China
Address No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
87GF Score

Get the complete analysis for HKSE:02607

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$11.40
Price
HK$14.54
GF Value